These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 208242)
1. Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus. de Noronha F; Schäfer W; Essex M; Bolognesi DP Virology; 1978 Apr; 85(2):617-21. PubMed ID: 208242 [No Abstract] [Full Text] [Related]
2. Group-specific cytolytic antibody directed against the major glycoprotein (gp70) of murine leukemia viruses in serum of mice with dormant FLV infections. Callahan RM; Marx PA; Wheelock EF Virology; 1979 Aug; 97(1):55-67. PubMed ID: 224581 [No Abstract] [Full Text] [Related]
3. Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus. Fischinger PJ; Sch5AAFER W; Bolognesi DP Virology; 1976 May; 71(1):169-84. PubMed ID: 58469 [No Abstract] [Full Text] [Related]
4. Prevention of oncornavirus-induced sarcomas in cats by treatment with antiviral antibodies. de Noronha F; Baggs R; Schäfer W; Bolognesi D Nature; 1977 May; 267(5606):54-6. PubMed ID: 193042 [No Abstract] [Full Text] [Related]
5. Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. II. Response in C57BL/6 mice. Ihle JN; Lee JC; Collins JJ; Fischinger PJ; Pazmino NH; Moennig V; Schäfer W; Hanna MG; Bolognesi DP Virology; 1976 Nov; 75(1):88-101. PubMed ID: 185805 [No Abstract] [Full Text] [Related]
6. Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat. Salerno RA; Lehman ED; Larson VM; Hilleman MR J Natl Cancer Inst; 1978 Dec; 61(6):1487-93. PubMed ID: 214605 [No Abstract] [Full Text] [Related]
7. Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated. Fischinger PJ; Ihle JN; Bolognesi DP; Schäfer W Virology; 1976 May; 71(1):346-51. PubMed ID: 179206 [No Abstract] [Full Text] [Related]
8. Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum. Hunsmann G; Moennig V; Schäfer W Virology; 1975 Jul; 66(1):327-9. PubMed ID: 1136142 [No Abstract] [Full Text] [Related]
9. Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice. Ihle JN; Denny TP; Bolognesi DP J Virol; 1976 Mar; 17(3):727-36. PubMed ID: 56459 [TBL] [Abstract][Full Text] [Related]
10. Subunit vaccines against exogenous retroviruses: overview and perspectives. Hunsmann G Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114 [TBL] [Abstract][Full Text] [Related]
11. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas. Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079 [TBL] [Abstract][Full Text] [Related]
12. Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein. Steeves RA; Strand M; August JT J Virol; 1974 Jul; 14(1):187-9. PubMed ID: 4134470 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. III. Influence on endogenous MuLV-mediated pathogenesis. Ihle JN; Collins JJ; Lee JC; Fischinger PJ; Pazmino N; Moennig V; Schäfer W; Hanna MG; Bolognesi DP Virology; 1976 Nov; 75(1):102-12. PubMed ID: 982843 [No Abstract] [Full Text] [Related]
14. Properties of mouse leukemia viruses. XVI. Suppression of spontaneous fetal leukemias in AKR mice by treatment with broadly reacting antibody against the viral glycoprotein gp 71. Schwarz H; Fischinger PJ; Ihle JN; Thiel HJ; Weiland F; Bolognesi DP; Schäfer W Virology; 1979 Feb; 93(1):159-74. PubMed ID: 433151 [No Abstract] [Full Text] [Related]
15. Active immunization with feline leukemia virus envelope glycoprotein suppresses growth of virus-induced feline sarcoma. Hunsmann G; Pedersen NC; Theilen GH; Bayer H Med Microbiol Immunol; 1983; 171(4):233-41. PubMed ID: 6304480 [TBL] [Abstract][Full Text] [Related]
16. Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells. Snyder HW; Hardy WD; Zuckerman EE; Fleissner E Nature; 1978 Oct; 275(5681):656-8. PubMed ID: 212681 [No Abstract] [Full Text] [Related]
17. Circulating antibodies to the feline leukemia virus and FOCMA in cats. Lizonová A; Grófová M Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice. Ihle JN; Collins JJ; Lee JC; Fischinger PJ; Moennig V; Schäfer W; Hanna MG; Bolognesi DP Virology; 1976 Nov; 75(1):74-87. PubMed ID: 982854 [No Abstract] [Full Text] [Related]
19. Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens. Lee TH; Essex M; de Noronha F; Azocar J Cancer Res; 1982 Oct; 42(10):3995-9. PubMed ID: 6286102 [TBL] [Abstract][Full Text] [Related]
20. Lysis of feline lymphoma cells by complement-dependent antibodies in feline leukemia virus contact cats. Correlation of lysis and antibodies to feline oncornavirus-associated cell membrane antigen. Grant CK; Essex M; Pedersen NC; Hardy WD; Stephenson JR; Cotter SM; Theilen GH J Natl Cancer Inst; 1978 Jan; 60(1):161-6. PubMed ID: 203702 [No Abstract] [Full Text] [Related] [Next] [New Search]